{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:45:03Z","timestamp":1791042303527,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The medical care of malaria is a clinical emergency because it may develop into severe malaria, which has a high risk of complications and death. One of the major complications of <jats:italic>Plasmodium falciparum<\/jats:italic> infections is cerebral malaria (CM), which is responsible for at least 175,000 deaths worldwide each year and has long-term neurological sequelae. Moreover, treatment for CM is only partially effective. Statins are now known to have anti-inflammatory action, to attenuate sepsis and to have neuroprotective effects. <jats:italic>In vitro,<\/jats:italic> atorvastatin (AVA) has an anti-malarial activity and has improved the activity of quinine (QN), mefloquine (MQ), and dihydroartemisinin (DHA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study had two objectives. First, the ability of AVA to enhance DHA efficacy by improving the survival rate for CM and also decreasing signs of CM was evaluated in a murine model of experimental cerebral malaria (ECM), which was designed in C57BL6\/N mice. Second, the inflammatory biomarkers were assessed at D6 and D10 in mice treated by DHA and in untreated mice in which clinical signs of CM appear rapidly and death occurs before D12. Both experiments were designed with seven days of treatment with 40\u00a0mg\/kg AVA combined with five days of 3\u00a0mg\/kg DHA administered intraperitoneally.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>AVA in combination with DHA in a therapeutic scheme leads to a significant delay in mouse death, and it has an effect on the onset of CM symptoms and on the level of parasitaemia. Evaluation of the biomarkers highlights the significant difference between treated and control mice for five cytokines and chemokines (Eotaxin-CCL11, IL-13, LIX-CXCL5, MIP1b-CCL4 and MIP2) that are known to have a role in chemotaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The combination of DHA and AVA seems to be effective as a therapeutic scheme for improving mouse survival but less effective for cytokine modulation, which is associated with protection against CM. These results call for clinical trials of AVA as an adjuvant with anti-malarial therapy, especially with artemisinin-based combination therapy, in CM treatment or prevention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-12-302","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T08:14:18Z","timestamp":1377850458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model"],"prefix":"10.1186","volume":"12","author":[{"given":"J\u00e9r\u00f4me","family":"Dormoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Briolant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Desgrouas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Travaill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"2913_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","volume":"366","author":"A Dondorp","year":"2005","unstructured":"Dondorp A, Nosten F, Stepniewska K, Day N, White N: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005, 366: 717-725.","journal-title":"Lancet"},{"key":"2913_CR2","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010, 376: 1647-1657. 10.1016\/S0140-6736(10)61924-1.","journal-title":"Lancet"},{"key":"2913_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","volume":"12","author":"C Amaratunga","year":"2012","unstructured":"Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM: Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012, 12: 851-858. 10.1016\/S1473-3099(12)70181-0.","journal-title":"Lancet Infect Dis"},{"key":"2913_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"2913_CR5","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359: 2619-2620. 10.1056\/NEJMc0805011.","journal-title":"N Engl J Med"},{"key":"2913_CR6","first-page":"317","volume":"22","author":"RA Rakotoarivelo","year":"2012","unstructured":"Rakotoarivelo RA, Razakarison C, Gottot S, Ravony Harintsoa L, Randrianiriana G, Andriamanjato D, Harilalarisoa H, Ramaniraka I, Rakotondramanga J, Rafaliarivony N, Ranaivoson F, Rakotonirina JF, Desplats D: Assessment of the management of cases of fever and malaria by general practitioners in the central Highlands of Madagascar, 2009\u20132010. Med Sante Trop. 2012, 22: 317-322.","journal-title":"Med Sante Trop"},{"key":"2913_CR7","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/cmdc.201200383","volume":"7","author":"RK Haynes","year":"2012","unstructured":"Haynes RK, Cheu KW, Chan HW, Wong HN, Li KY, Tang MM, Chen MJ, Guo ZF, Guo ZH, Sinniah K, Witte AB, Coghi P, Monti D: Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model-A unifying proposal for drug action. Chem Med Chem. 2012, 7: 2204-2226.","journal-title":"Chem Med Chem"},{"key":"2913_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1017\/S003118201200176X","volume":"140","author":"SK Pandey","year":"2012","unstructured":"Pandey SK, Dwivedi H, Singh S, Siddiqui WA, Tripathi R: Antimalarial interaction of quinine and quinidine with clarithromycin. Parasitology. 2012, 140: 406-413.","journal-title":"Parasitology"},{"key":"2913_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1368-7646(98)80208-2","volume":"1","author":"NJ White","year":"1998","unstructured":"White NJ: Preventing antimalarial drug resistance through combinations. Drug Resist Updat. 1998, 1: 3-9. 10.1016\/S1368-7646(98)80208-2.","journal-title":"Drug Resist Updat"},{"key":"2913_CR10","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1128\/AAC.01330-06","volume":"51","author":"B Pradines","year":"2007","unstructured":"Pradines B, Torrentino-Madamet M, Fontaine A, Henry M, Baret E, Mosnier J, Briolant S, Fusai T, Rogier C: Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother. 2007, 51: 2654-2655. 10.1128\/AAC.01330-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"2913_CR11","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1128\/AAC.01462-08","volume":"53","author":"V Parquet","year":"2009","unstructured":"Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, Amalvict R, Baret E, Fusai T, Rogier C, Pradines B: Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2009, 53: 2248-2252. 10.1128\/AAC.01462-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2913_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/jac\/dkq173","volume":"65","author":"N Wurtz","year":"2010","unstructured":"Wurtz N, Briolant S, Gil M, Parquet V, Henry M, Baret E, Amalvict R, Almeras L, Rogier C, Pradines B: Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. J Antimicrob Chemother. 2010, 65: 1387-1394. 10.1093\/jac\/dkq173.","journal-title":"J Antimicrob Chemother"},{"key":"2913_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-9-139","volume":"9","author":"V Parquet","year":"2010","unstructured":"Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, Gil M, Baret E, Amalvict R, Rogier C, Pradines B: Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malar J. 2010, 9: 139-10.1186\/1475-2875-9-139.","journal-title":"Malar J"},{"key":"2913_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1128\/AAC.01006-09","volume":"54","author":"H Savini","year":"2010","unstructured":"Savini H, Souraud JB, Briolant S, Baret E, Amalvict R, Rogier C, Pradines B: Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin. Antimicrob Agents Chemother. 2010, 54: 966-967. 10.1128\/AAC.01006-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"2913_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00216-006-0655-3","volume":"386","author":"V Borek-Dohalsky","year":"2006","unstructured":"Borek-Dohalsky V, Huclova J, Barrett B, Nemec B, Ulc I, Jelinek I: Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. Anal Bioanal Chem. 2006, 386: 275-285. 10.1007\/s00216-006-0655-3.","journal-title":"Anal Bioanal Chem"},{"key":"2913_CR16","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1128\/AAC.00513-08","volume":"52","author":"AL Bienvenu","year":"2008","unstructured":"Bienvenu AL, Picot S: Statins alone are ineffective in cerebral malaria but potentiate artesunate. Antimicrob Agents Chemother. 2008, 52: 4203-4204. 10.1128\/AAC.00513-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2913_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2875-11-13","volume":"11","author":"JB Souraud","year":"2012","unstructured":"Souraud JB, Briolant S, Dormoi J, Mosnier J, Savini H, Baret E, Amalvict R, Soulard R, Rogier C, Pradines B: Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model. Malar J. 2012, 11: 13-10.1186\/1475-2875-11-13.","journal-title":"Malar J"},{"key":"2913_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/CMR.14.4.810-820.2001","volume":"14","author":"J Lou","year":"2001","unstructured":"Lou J, Lucas R, Grau GE: Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001, 14: 810-820. 10.1128\/CMR.14.4.810-820.2001. table of contents","journal-title":"Clin Microbiol Rev"},{"key":"2913_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2164-8-452","volume":"8","author":"NF Delahaye","year":"2007","unstructured":"Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, Joly F, Iraqi FA, Grau GE, Nguyen C, Rihet P: Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics. 2007, 8: 452-10.1186\/1471-2164-8-452.","journal-title":"BMC Genomics"},{"key":"2913_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2990.2006.00706.x","volume":"32","author":"P Lackner","year":"2006","unstructured":"Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E: Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol. 2006, 32: 177-188. 10.1111\/j.1365-2990.2006.00706.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2913_CR21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1128\/AAC.01428-07","volume":"52","author":"R Kobbe","year":"2008","unstructured":"Kobbe R, Schreiber N, May J, Jacobs T: Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria. Antimicrob Agents Chemother. 2008, 52: 1583-1584. 10.1128\/AAC.01428-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"2913_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.4269\/ajtmh.2009.09-0204","volume":"81","author":"AJ Helmers","year":"2009","unstructured":"Helmers AJ, Gowda DC, Kain KC, Liles WC: Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages. Am J Trop Med Hyg. 2009, 81: 631-637. 10.4269\/ajtmh.2009.09-0204.","journal-title":"Am J Trop Med Hyg"},{"key":"2913_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1475-2875-5-116","volume":"5","author":"P Lackner","year":"2006","unstructured":"Lackner P, Beer R, Helbok R, Broessner G, Engelhardt K, Brenneis C, Schmutzhard E, Pfaller K: Scanning electron microscopy of the neuropathology of murine cerebral malaria. Malar J. 2006, 5: 116-10.1186\/1475-2875-5-116.","journal-title":"Malar J"},{"key":"2913_CR24","doi-asserted-by":"publisher","first-page":"e4317","DOI":"10.1371\/journal.pone.0004317","volume":"4","author":"VA White","year":"2009","unstructured":"White VA, Lewallen S, Beare NA, Molyneux ME, Taylor TE: Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One. 2009, 4: e4317-10.1371\/journal.pone.0004317.","journal-title":"PLoS One"},{"key":"2913_CR25","doi-asserted-by":"publisher","first-page":"e1003099","DOI":"10.1371\/journal.ppat.1003099","volume":"8","author":"PA Reis","year":"2012","unstructured":"Reis PA, Estato V, da Silva TI, D\u2019Avila JC, Siqueira LD, Assis EF, Bozza PT, Bozza FA, Tibiri\u00e7a EV, Zimmerman GA, Castro-Faria-Neto HC: Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog. 2012, 8: e1003099-10.1371\/journal.ppat.1003099.","journal-title":"PLoS Pathog"},{"key":"2913_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000180268","volume":"16","author":"YC Martins","year":"2009","unstructured":"Martins YC, Carvalho LJ, Daniel-Ribeiro CT: Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation. 2009, 16: 134-145. 10.1159\/000180268.","journal-title":"Neuroimmunomodulation"},{"key":"2913_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1471-4906(03)00229-1","volume":"24","author":"NH Hunt","year":"2003","unstructured":"Hunt NH, Grau GE: Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24: 491-499. 10.1016\/S1471-4906(03)00229-1.","journal-title":"Trends Immunol"},{"key":"2913_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/expr.2000.4508","volume":"95","author":"LJ Carvalho","year":"2000","unstructured":"Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF: Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol. 2000, 95: 1-7. 10.1006\/expr.2000.4508.","journal-title":"Exp Parasitol"},{"key":"2913_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1475-2875-10-52","volume":"10","author":"Z Taoufiq","year":"2011","unstructured":"Taoufiq Z, Pino P, N\u2019Dilimabaka N, Arrouss I, Assi S, Soubrier F, Rebollo A, Mazier D: Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. Malar J. 2011, 10: 52-10.1186\/1475-2875-10-52.","journal-title":"Malar J"},{"key":"2913_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS: Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006, 6: 358-370. 10.1038\/nri1839.","journal-title":"Nat Rev Immunol"},{"key":"2913_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Mason JC: Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007, 28: 88-98. 10.1016\/j.it.2006.12.003.","journal-title":"Trends Immunol"},{"key":"2913_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00228-006-0203-2","volume":"62","author":"PN Newton","year":"2006","unstructured":"Newton PN, Barnes KI, Smith PJ, Evans AC, Chierakul W, Ruangveerayuth R, White NJ: The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Eur J Clin Pharmacol. 2006, 62: 1003-1009. 10.1007\/s00228-006-0203-2.","journal-title":"Eur J Clin Pharmacol"},{"key":"2913_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.5551\/jat.5660","volume":"17","author":"H Arai","year":"2010","unstructured":"Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M: More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome. J Atheroscler Thromb. 2010, 17: 1096-1107. 10.5551\/jat.5660.","journal-title":"J Atheroscler Thromb"},{"key":"2913_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1542\/peds.2004-2090","volume":"116","author":"SB Clauss","year":"2005","unstructured":"Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO: Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005, 116: 682-688. 10.1542\/peds.2004-2090.","journal-title":"Pediatrics"},{"key":"2913_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jjcc.2010.02.003","volume":"55","author":"S Miura","year":"2010","unstructured":"Miura S, Saku K: Effects of statin and lipoprotein metabolism in heart failure. J Cardiol. 2010, 55: 287-290. 10.1016\/j.jjcc.2010.02.003.","journal-title":"J Cardiol"},{"key":"2913_CR36","doi-asserted-by":"publisher","first-page":"a2423","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ, Sijbrands EJ: Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ. 2008, 337: a2423-10.1136\/bmj.a2423.","journal-title":"BMJ"},{"key":"2913_CR37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.49.4.526","volume":"49","author":"Y Ohtsuka","year":"2001","unstructured":"Ohtsuka Y, Lee J, Stamm DS, Sanderson IR: MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 2001, 49: 526-533. 10.1136\/gut.49.4.526.","journal-title":"Gut"},{"key":"2913_CR38","first-page":"1854","volume":"39","author":"XT Yan","year":"1998","unstructured":"Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN: Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 1998, 39: 1854-1862.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2913_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T: The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011, 477: 90-94. 10.1038\/nature10357.","journal-title":"Nature"},{"key":"2913_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/mi.2012.109","volume":"6","author":"M Isgro","year":"2013","unstructured":"Isgro M, Bianchetti L, Marini MA, Bellini A, Schmidt M, Mattoli S: The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma. Mucosal Immunol. 2013, 6: 718-724. 10.1038\/mi.2012.109.","journal-title":"Mucosal Immunol"},{"key":"2913_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1172\/JCI60588","volume":"122","author":"J Mei","year":"2012","unstructured":"Mei J, Liu Y, Dai N, Hoffmann C, Hudock KM, Zhang P, Guttentag SH, Kolls JK, Oliver PM, Bushman FD, Worthen GS: Cxcr2 and Cxcl5 regulate the IL-17\/G-CSF axis and neutrophil homeostasis in mice. J Clin Invest. 2012, 122: 974-986. 10.1172\/JCI60588.","journal-title":"J Clin Invest"},{"key":"2913_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4049\/jimmunol.1202286","volume":"190","author":"J Song","year":"2013","unstructured":"Song J, Wu C, Zhang X, Sorokin LM: In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1beta-induced peritonitis. J Immunol. 2013, 190: 401-410. 10.4049\/jimmunol.1202286.","journal-title":"J Immunol"},{"key":"2913_CR43","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/hep.25907","volume":"56","author":"SL Zhou","year":"2012","unstructured":"Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J: Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012, 56: 2242-2254. 10.1002\/hep.25907.","journal-title":"Hepatology"},{"key":"2913_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-3024.2011.01329.x","volume":"33","author":"CJ Clark","year":"2011","unstructured":"Clark CJ, Phillips RS: Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain. Parasite Immunol. 2011, 33: 637-641. 10.1111\/j.1365-3024.2011.01329.x.","journal-title":"Parasite Immunol"},{"key":"2913_CR45","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/IAI.73.4.2564-2567.2005","volume":"73","author":"M Steigerwald","year":"2005","unstructured":"Steigerwald M, Moll H: Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect Immun. 2005, 73: 2564-2567. 10.1128\/IAI.73.4.2564-2567.2005.","journal-title":"Infect Immun"},{"key":"2913_CR46","first-page":"62","volume":"7","author":"R Basir","year":"2012","unstructured":"Basir R, Rahiman SF, Hasballah K, Chong W, Talib H, Yam M, Jabbarzare M, Tie T, Othman F, Moklas M, Abdullah W, Ahmad Z: Plasmodium berghei ANKA infection in ICR mice as a model of cerebral malaria. Iran J Parasitol. 2012, 7: 62-74.","journal-title":"Iran J Parasitol"},{"key":"2913_CR47","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4049\/jimmunol.1200688","volume":"189","author":"A Villegas-Mendez","year":"2012","unstructured":"Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stumhofer JS, Hafalla JC, Blount DG, Hunter CA, Riley EM, Couper KN: IFN-gamma-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol. 2012, 189: 968-979. 10.4049\/jimmunol.1200688.","journal-title":"J Immunol"},{"key":"2913_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.12.022","volume":"189","author":"A Niessner","year":"2006","unstructured":"Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J: Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis. 2006, 189: 408-413. 10.1016\/j.atherosclerosis.2005.12.022.","journal-title":"Atherosclerosis"},{"key":"2913_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1473-3099(07)70111-1","volume":"7","author":"M Terblanche","year":"2007","unstructured":"Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007, 7: 358-368. 10.1016\/S1473-3099(07)70111-1.","journal-title":"Lancet Infect Dis"},{"key":"2913_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1155\/2011\/828256","volume":"30","author":"NO Wilson","year":"2011","unstructured":"Wilson NO, Jain V, Roberts CE, Lucchi N, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK: CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers. 2011, 30: 39-49. 10.1155\/2011\/828256.","journal-title":"Dis Markers"},{"key":"2913_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2875-10-69","volume":"10","author":"BY Sarfo","year":"2011","unstructured":"Sarfo BY, Wilson NO, Bond VC, Stiles JK: Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL\/6 mice. Malar J. 2011, 10: 69-10.1186\/1475-2875-10-69.","journal-title":"Malar J"},{"key":"2913_CR52","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.4049\/jimmunol.1101978","volume":"188","author":"M Fauconnier","year":"2012","unstructured":"Fauconnier M, Palomo J, Bourigault ML, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux VF: IL-12Rbeta2 is essential for the development of experimental cerebral malaria. J Immunol. 2012, 188: 1905-1914. 10.4049\/jimmunol.1101978.","journal-title":"J Immunol"},{"key":"2913_CR53","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0140-6736(97)09439-7","volume":"351","author":"JA Kurtzhals","year":"1998","unstructured":"Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998, 351: 1768-1772. 10.1016\/S0140-6736(97)09439-7.","journal-title":"Lancet"},{"key":"2913_CR54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/intimm\/dxg065","volume":"15","author":"PS Hanum","year":"2003","unstructured":"Hanum PS, Hayano M, Kojima S: Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol. 2003, 15: 633-640. 10.1093\/intimm\/dxg065.","journal-title":"Int Immunol"},{"key":"2913_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1475-2875-9-85","volume":"9","author":"YC Martins","year":"2010","unstructured":"Martins YC, Werneck GL, Carvalho LJ, Silva BP, Andrade BG, Souza TM, Souza DO, Daniel-Ribeiro CT: Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol. Malar J. 2010, 9: 85-10.1186\/1475-2875-9-85.","journal-title":"Malar J"},{"key":"2913_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/cc2183","volume":"7","author":"A Trampuz","year":"2003","unstructured":"Trampuz A, Jereb M, Muzlovic I, Prabhu RM: Clinical review: severe malaria. Crit Care. 2003, 7: 315-323. 10.1186\/cc2183.","journal-title":"Crit Care"},{"key":"2913_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2004.043893","volume":"76","author":"JA Carter","year":"2005","unstructured":"Carter JA, Mung\u2019ala-Odera V, Neville BG, Murira G, Mturi N, Musumba C, Newton CR: Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry. 2005, 76: 476-481. 10.1136\/jnnp.2004.043893.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2913_CR58","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1542\/peds.2006-2027","volume":"119","author":"MJ Boivin","year":"2007","unstructured":"Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, John CC: Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007, 119: e360-e366. 10.1542\/peds.2006-2027.","journal-title":"Pediatrics"},{"key":"2913_CR59","unstructured":"Water and lipid soluble statins: [https:\/\/www.gpnotebook.co.uk\/simplepage.cfm?ID=x20120104193906598025]"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:16:56Z","timestamp":1630545416000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-302","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]},"assertion":[{"value":"8 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"302"}}